Harry Kopelman

No open positions remaining

Health Technology

Consumer Services

Finance

Profile

Dr. Harry Kopelman, MD, is Scientific Advisor at Easton Capital Investment Group.
Dr. Kopelman is a graduate of the Georgetown University School of Medicine, Washington, D.C.
(1980).
He completed his internship/residency at North Carolina Memorial Hospital/University of North Carolina, Chapel Hill (1983).
His fellowship in Cardiovascular Disease and Cardiac Electrophysiology was at the Vanderbilt University School of Medicine in Nashville, TN (1985).

Former positions of Harry Kopelman

Companies	Position	End
Arterain Medical, Inc. Arterain Medical, Inc. Medical SpecialtiesHealth Technology Develops medical devices to treat large vessel acute ischemic strokes	Director/Board Member	-
Easton Capital Investment Group Easton Capital Investment Group Investment ManagersFinance Easton invests in all segments of the healthcare industry, including biopharmaceuticals, drug delivery, medical devices and healthcare services. The firm is stage-agnostic and considers opportunities from early-stage venture capital to later-stage growth capital with investment size ranging from $0.05 - $10 million. They are generally not a seed-stage investor.	Corporate Officer/Principal	-

See the detail of Harry Kopelman's experience

Training of Harry Kopelman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Harry Kopelman's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Arterain Medical, Inc. Arterain Medical, Inc. Medical SpecialtiesHealth Technology Develops medical devices to treat large vessel acute ischemic strokes	Health Technology
Georgetown University Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Easton Capital Investment Group Easton Capital Investment Group Investment ManagersFinance Easton invests in all segments of the healthcare industry, including biopharmaceuticals, drug delivery, medical devices and healthcare services. The firm is stage-agnostic and considers opportunities from early-stage venture capital to later-stage growth capital with investment size ranging from $0.05 - $10 million. They are generally not a seed-stage investor.	Finance